| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Inhibrx Biosciences, Inc. (INBX) has 5 insiders with recent SEC Form 4 filings, including 20 buys and 3 sells. INBX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 102.9K | $13.82M | - | |
| Dir | 15.0K | $2.02M | - | |
| Dir | 15.0K | $2.02M | - | |
| Dir | 15.0K | $2.02M | - | |
| Dir | 15.0K | $2.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Viking Global Investors LP66 | - | Sell | 350,000 | $32.25 | $11,287,500.00 | -19.6% | +129.5% | - | |
| Nov 20, 2024 | Kayyem Jon Faiz51 | Director | Buy | 107,186 | $14.21 | $1,523,619.50 | +79.6% | -6.9% | +468.7% | |
| Oct 3, 2024 | Vuori Kristiina Md76 | Director | Buy | 6,667 | $15.00 | $100,005.00 | +48.4% | +2.5% | +139.6% | |
| Sep 16, 2024 | Lappe Mark87 | Chief Executive Officer | Buy | 40,000 | $15.73 | $629,116.96 | +2.9% | -16.5% | +52.4% | |
| Sep 11, 2024 | Vuori Kristiina Md76 | Director | Buy | 6,636 | $15.07 | $99,991.99 | +45.9% | -0.2% | +89.7% | |
| Sep 10, 2024 | Lappe Mark87 | Chief Executive Officer | Buy | 44,000 | $15.25 | $671,150.00 | +2.3% | -1.7% | +82.1% | |
| Sep 3, 2024 | Lappe Mark87 | Chief Executive Officer | Buy | 40,000 | $14.92 | $596,762.80 | +7.1% | -5.5% | +74.3% | |
| Aug 29, 2024 | Vuori Kristiina Md76 | Director | Buy | 7,140 | $14.00 | $99,960.00 | New | +12.4% | +102.7% | |
| Aug 28, 2024 | Manhard Kimberly80 | Director | Buy | 10,000 | $13.98 | $139,800.00 | New | +10.7% | +99.7% | |
| Aug 23, 2024 | Forsyth Douglas | Director | Buy | 75,000 | $13.83 | $1,037,328.16 | +23.9% | +4.8% | +87.4% |